PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AnaSpec Introduces a Wide Selection of SYBR® qPCR MasterMixes and Core Kits - AnaSpec, EGT Group offers a wide selection of SYBR® Green-based MasterMixes and Core Kits for almost any thermocycler available in the industry
AnaSpec Introduces a Wide Selection of SYBR® qPCR MasterMixes and Core Kits

 

NewswireToday - /newswire/ - Fremont, CA, United States, 2013/01/10 - AnaSpec, EGT Group offers a wide selection of SYBR® Green-based MasterMixes and Core Kits for almost any thermocycler available in the industry.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

AnaSpec, EGT Group is pleased to offer a wide selection of SYBR® Green-based MasterMixes and Core Kits for almost any thermocycler available in the industry. The MESA (Maximize & Enhance your SYBR® Assays) MasterMixes use our new powerful MeteorTaq hotstart polymerase.

The MESA BLUE kits contain a proprietary inert BLUE dye that aids in the visualization of reagent dispensed, thus avoiding aberrant results before they occur. Our CORE kits are unique in the industry in that they are probably the only format in the industry that provide users with the ability to titrate SYBR® Green amount as part of the optimization process.

AnaSpec, EGT Group’s qPCR MasterMixes:

• Reduce run times with uncompromised results
• Tailored for highly sensitive assays
• Optimized for maximum consistency and specificity
• Large dynamic range
• Save at least 25% in price compared to reagents from instrument vendors

Available in BLUE format
• New proprietary inert BLUE dye
• Clear visual dispensing of the reagent

2012 Product Citations
MESA FAST for SYBR® Assays
Zong, Y. et al. PNAS 109, E3395 (2012).
Moreau, M. et al. Plant Cell 24, 463 (2012).

MESA Green for SYBR® Assays
Soto-Rifo, R. et al. Nucleic Acids Res 40, 2653 (2012).
Cobo, ER. et al. Infect Immun 80, 143 (2012).
Steinsiek, S. K. Bettenbrock, J Bacteriol 194, 5897 (2012).

MESA BLUE for SYBR® Assays
Rast, MI. and R. Simon, Plant Cell 24, 2917 (2012).
Bosch, D. and A. Saiardi, J Biol Chem 287, 38347 (2012).
Fichelson, P. et al. PNAS 109, 7893 (2012).

Core Kits
Zhang, L. et al. Plant Physiol 160, 1453 (2012).

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Introduces a Wide Selection of SYBR® qPCR MasterMixes and Core Kits

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Cecilia Po - AnaSpec.com 
510-791-9560 cecilia[.]anaspec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)